Loading...
An Isotoxic Planning Comparison Study for Stage II-III Non-small Cell Lung Cancer: Is Intensity-modulated Radiotherapy the Answer?
Warren, Mark Webster, G Ryder, W David J Rowbottom, Carl G
Warren, Mark
Webster, G
Ryder, W David J
Rowbottom, Carl G
Citations
Altmetric:
Abstract
Recent clinical series suggest that treating patients with isotoxic twice-daily radiotherapy may be beneficial. This dosimetric planning study compared the use of intensity-modulated radiotherapy (IMRT) and three-dimensional conformal radiotherapy (3DRT) to deliver isotoxic treatment for non-small cell lung cancer (NSCLC) patients.
Description
Date
2014-05-01
Publisher
Collections
Keywords
Type
Article
Citation
An Isotoxic Planning Comparison Study for Stage II-III Non-small Cell Lung Cancer: Is Intensity-modulated Radiotherapy the Answer? 2014: Clin Oncol